ProAxsis Presenting New Data on NEATstik and New High Sensitivity Neutrophil Elastase Immunoassay at ATS 2018
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
New opportunity for Early Stage Researcher at Queen’s University Belfast
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
NEATSTIK®ProAxsis abstracts at 2017 British Thoracic Society Winter Meeting
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis to showcase ProteaseTag® abstracts at 2017 North American Cystic Fibrosis Conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis abstracts at 2017 European Respiratory Society Conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis CEO to present at Anglonordic Conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis abstracts at 2017 American Thoracic Society Conference
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProAxsis CEO to present update at Bio-Europe Spring
ProAxsis (www.proaxsis.com), the Belfast-based diagnostics company, today announces that it will be conducting a collaborative 12-month project with the Northern Ireland Connected Health Innovation Centre (CHIC), based at Ulster University. The project will focus on the development of a quantitative lateral flow device designed to monitor the ongoing clinical status of patients with respiratory diseases […]
ProteaseTag® Active Neutrophil Elastase Immunoassay used to predict future risk of exacerbation in bronchiectasis
In a significant new study, a team at the University of Dundee has shown for the first time that sputum neutrophil elastase (NE) activity, when measured using the ProteaseTag® Active NE Immunoassay, is a biomarker of disease severity and future risk of exacerbation in adults with bronchiectasis. The full text of the University of Dundee […]
ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016
ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016 WP_Developer May 20, 2022 Recent Posts ProAxsis’ ProteaseTag® NE Immunoassay highlighted at BTS 2016May 20, 2022 ProAxsis shortlisted for Small Business of the Year AwardMay 20, 2022 ProAxsis gains further support from Innovate UKMay 20, 2022 Have Any Questions? Lorem ipsum dolor sit amet consectetur adipiscing elit. […]
